OLIPHANT LAURA 4

What Happened

• Laura Oliphant, a director of Aehr Test Systems (AEHR), reported a sale of 3,000 shares on 2026-04-09. The shares were disposed at $68.36 each for a total transaction value of approximately $205,073. The Form 4 reporting this transaction was filed on 2026-04-10. This was a sale (not a purchase), which is often routine insider selling rather than a buy signal.

Key Details

• Transaction date and price: 2026-04-09, 3,000 shares at $68.36 per share.
• Total proceeds: approximately $205,073.
• Reporting filed: Form 4 filed 2026-04-10 (one day after the trade) — timely under Form 4 rules.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — "The amount reported includes shares subject to unvested restricted stock units."
• Transaction type/code: Sale reported as "S" (open market or private sale).

Context

• Sales by directors can be routine (portfolio diversification, tax/liquidity needs) and do not by themselves indicate a change in company outlook. The footnote about unvested restricted stock units relates to reporting of holdings and may affect how ownership is presented on the Form 4; it does not, by itself, explain the reason for the sale.